Compare UFG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFG | HBIO |
|---|---|---|
| Founded | 2021 | 1901 |
| Country | Singapore | United States |
| Employees | 17 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 25.7M |
| IPO Year | N/A | 2000 |
| Metric | UFG | HBIO |
|---|---|---|
| Price | $0.94 | $6.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 71.8K | ★ 72.3K |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | $3.95 | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | $211.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $0.28 |
| 52 Week High | $9.91 | $7.00 |
| Indicator | UFG | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 70.00 |
| Support Level | $0.94 | $0.47 |
| Resistance Level | $1.01 | N/A |
| Average True Range (ATR) | 0.07 | 0.52 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 67.68 | 90.85 |
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.